IFP Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

IFP Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$6K	Sell	1,250 -19	-1%	-$94	﹤0.01%	1830
2018 Q4	$3K	Hold	1,269	–	–	﹤0.01%	3106
2018 Q3	$8K	Hold	1,269	–	–	﹤0.01%	3025
2018 Q2	$9K	Hold	1,269	–	–	﹤0.01%	3003
2018 Q1	$12K	Hold	1,269	–	–	﹤0.01%	2701
2017 Q4	$12K	Hold	1,269	–	–	﹤0.01%	2739
2017 Q3	$15K	Buy	1,269 +1,019	+408%	+$38.7K	﹤0.01%	2809
2017 Q2	$10K	Buy	+250	New	+$12K	﹤0.01%	3056
2017 Q1	–	Sell	-625	Closed	-$21K	–	4239
2016 Q4	$21K	Buy	+625	New	+$20.6K	﹤0.01%	2445
2016 Q3	–	Sell	-875	Closed	-$29K	–	4142
2016 Q2	$29K	Sell	875 -375	-30%	-$13.7K	﹤0.01%	2119
2016 Q1	$6K	Buy	+1,250	New	+$39.7K	﹤0.01%	1822

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

IFP Advisors's GNCA Position: Q1 2019 in Review

IFP Advisors reduced its Genocea Biosciences, Inc. (GNCA) stake by 1.5% in Q1 2019, selling an estimated $94 and leaving 1,250 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

IFP Advisors first reported a position in GNCA in Q1 2016 and has held it in 11 quarters since. The position peaked at $29K in Q2 2016. 41 funds tracked by Wall St. Rank hold GNCA as of Q1 2019.

IFP Advisors held 1,250 shares of Genocea Biosciences, Inc. worth $6K as of Q1 2019.
IFP Advisors sold 19 Genocea Biosciences, Inc. shares in Q1 2019, an estimated $94.
Genocea Biosciences, Inc. made up ﹤0.01% of IFP Advisors's portfolio in Q1 2019, its #1830 holding.
IFP Advisors first reported a position in Genocea Biosciences, Inc. in Q1 2016 and has held it in 11 quarters since.
IFP Advisors's Genocea Biosciences, Inc. position peaked at $29K in Q2 2016.
41 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.